| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Germany | 3 | |
| #3 | EPO (European Patent Office) | 3 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement | |
| #4 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Therapeutic chemical compounds | |
| #5 | Measuring microorganism processes | |
| #6 | Animal care | |
| #7 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Michelfelder Stefan | 5 |
| #2 | Trepel Martin | 5 |
| #3 | Körbelin Jakob | 3 |
| #4 | Zahner Gunther | 2 |
| #5 | Stahl Rolf | 2 |
| #6 | Kluwe Lan | 2 |
| #7 | Koerbelin Jakob | 2 |
| #8 | Eschenhagen Thomas | 1 |
| #9 | Stimpel Doreen | 1 |
| #10 | Voit Thomas | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP2946663A1 | Genetically engineered murine animal as a model for Primary Membraneous Nephropathy | |
| DE102014207498A1 | Viral vector for targeted gene transfer in the brain and spinal cord | |
| WO2014170470A1 | Gene-therapy vectors for treating cardiomyopathy | |
| DE102013221452B3 | Method for determining the efficacy and / or specificity of an active substance | |
| DE102013215817A1 | NEW PEPTIDES WITH SPECIFICITY FOR THE LUNG |